Fiji vs Hong Kong, China: Tuberculosis patients living with HIV receiving antiretroviral therapy

Fiji
28 patients
in 2021
Hong Kong, China
27 patients
in 2021
Fiji rank
95th
Hong Kong, China rank
96th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Fiji
  • Hong Kong, China
0102030200320122021

How they compare

Fiji currently reports 28 patients against 27 patients in Hong Kong, China, a difference of 1 patients.

The two have swapped places 3 times across 14 shared years of data; in 2003 it was Hong Kong, China ahead.

Fiji ranks 95th and Hong Kong, China ranks 96th of 183 countries.

Across the 3 decades both report, Fiji averaged higher in 2 and Hong Kong, China in 1.

Head to head by decade

Decade Fiji Hong Kong, China Difference Ahead
2000s 0.3333 patients 12.33 patients 12 patients Hong Kong, China
2010s 10.33 patients 9.17 patients 1.17 patients Fiji
2020s 22.5 patients 17.5 patients 5 patients Fiji

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Fiji or Hong Kong, China?
Fiji, at 28 patients against 27 patients in Hong Kong, China as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Fiji and Hong Kong, China?
1 patients, with Fiji ahead.
How many years of comparable data are there for Fiji and Hong Kong, China?
14 years are reported by both, from 2003 to 2021.
How do Fiji and Hong Kong, China rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Fiji ranks 95th and Hong Kong, China ranks 96th of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Fiji vs Hong Kong, China: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 15 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/fiji/hong-kong-sar-china/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/fiji/hong-kong-sar-china/">Fiji vs Hong Kong, China: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.